Get the Stockscreener App
0.45
0.20%
-0.0009
After Hours:
.46
0.01
+2.22%
Harvard Bioscience Inc stock is traded at $0.45, with a volume of 1.17M.
It is down -0.20% in the last 24 hours and down -15.37% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.4509
Open:
$0.45
24h Volume:
1.17M
Relative Volume:
0.10
Market Cap:
$19.90M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-2.25
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
+4.51%
1M Performance:
-15.37%
6M Performance:
-76.92%
1Y Performance:
-85.39%
1-Day Range:
$0.4441
$0.495
1-Week Range:
$0.3859
$0.495
52-Week Range:
$0.2813
$3.445
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.45 | 19.04M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
What analysts say about Harvard Bioscience Inc. stockTriple-digit growth rates - Autocar Professional
What drives Harvard Bioscience Inc. stock priceBreakthrough profits - PrintWeekIndia
Harvard Bioscience announces CEO succession plan - MSN
Is Harvard Bioscience Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com
Harvard Bioscience Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
Harvard Bioscience stock holds Speculative Buy rating at Benchmark - Investing.com India
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board - GlobeNewswire
Harvard Bioscience Announces CEO Succession Plan - TipRanks
Harvard Bioscience names John Duke as new CEO as Jim Green retires By Investing.com - Investing.com South Africa
Harvard Bioscience names John Duke as new CEO as Jim Green retires - Investing.com
Harvard Bioscience Taps Growth Expert as New CEO: Former Corning Executive Brings 20% Annual Growth Record - Stock Titan
How Harvard Bioscience Inc. stock performs during market volatilitySafe and Scalable Investment Tips - Newser
Why Harvard Bioscience Inc. stock attracts strong analyst attentionDaily Breakout Picks - Newser
What makes Harvard Bioscience Inc. stock price move sharplyBreakout Confirmation Tool - Newser
Harvard Bioscience (NASDAQ:HBIO) versus Electronic Sensor Technologies (OTCMKTS:ESNR) Financial Comparison - Defense World
Is Harvard Bioscience, Inc. technically bullish or bearish? - MarketsMojo
Harvard Bioscience falls out of Nasdaq compliance after board member resignation - Worcester Business Journal
Harvard Bioscience Faces Nasdaq Compliance Challenge - TipRanks
Financial Fitness Check: Examining Harvard Bioscience Inc (HBIO)’s Key Ratios - DWinneX
Major Improvements In Harvard Bioscience Inc (HBIO) Stock Need To Be Considered - Stocksregister
Harvard Bioscience appoints new board member as director steps down - Worcester Business Journal
What Did We Find About Insider Trading At Harvard Bioscience Inc (NASDAQ: HBIO)? - Stocksregister
Harvard Bioscience Appoints John Duke to Board of Directors - The Manila Times
Harvard Bioscience appoints new board member By Investing.com - Investing.com South Africa
Harvard Bioscience Approves Incentive Plan Amendment - TipRanks
Harvard Bioscience appoints new board member - Investing.com
Harvard Bioscience Appoints John Duke to Board of Directors | HB - GuruFocus
Harvard Bioscience Strengthens Board with Ex-Corning Life Sciences Leader John Duke, Names New Lead Director - Stock Titan
Little Excitement Around Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Revenues As Shares Take 26% Pounding - simplywall.st
Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark - Yahoo Finance
Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions - MSN
Harvard Bioscience (HBIO): Analyst Lowers Price Target, Maintains Rating | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Target Price Reduced Amid Market Challenges | HBIO Stock News - GuruFocus
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):